カテゴリ： MarketLine, ベルギー, 企業調査

Groupe Bruxelles Lambert SA：企業の戦略・SWOT・財務情報

◆英語タイトル：Groupe Bruxelles Lambert SA - Strategy, SWOT and Corporate Finance Report
◆商品コード：DATA904C10192
◆発行会社（調査会社）：MarketLine
◆発行日：2018年11月
◆ページ数：46
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：ベルギー
◆産業分野：サービス
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD175 ⇒換算￥25,900見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD350 ⇒換算￥51,800見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD525 ⇒換算￥77,700見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Groupe Bruxelles Lambert SA – Strategy, SWOT and Corporate Finance Report
Summary

Groupe Bruxelles Lambert SA – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Groupe Bruxelles Lambert SA (GBL or ‘the company’) is an investment holding company, managing a portfolio of industrial investments in Europe. As of December 31, 2016, the company’s portfolio included Total, SGS, Imerys, LafargeHolcim, Pernod Ricard, SGS, Umicore, and the Sienna Capital. GBL operates in Asia, Latin America, Europe, North America, Middle East and Africa. It is headquartered in Brussels, Belgium.

Scope

- Detailed information on Groupe Bruxelles Lambert SA required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Groupe Bruxelles Lambert SA in the form of a SWOT analysis
- An in-depth view of the business model of Groupe Bruxelles Lambert SA including a breakdown and examination of key business segments
- Intelligence on Groupe Bruxelles Lambert SA’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Groupe Bruxelles Lambert SA, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Groupe Bruxelles Lambert SA and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Groupe Bruxelles Lambert SA as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Groupe Bruxelles Lambert SA’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
Groupe Bruxelles Lambert SA: Company Overview 9
Groupe Bruxelles Lambert SA: Overview and Key Facts 9
Groupe Bruxelles Lambert SA: Overview 9
Groupe Bruxelles Lambert SA: Key Facts 9
Groupe Bruxelles Lambert SA: Key Employees 10
Groupe Bruxelles Lambert SA: Key Employee Biographies 11
Groupe Bruxelles Lambert SA: Major Products and Services 19
Groupe Bruxelles Lambert SA: Company History 20
Groupe Bruxelles Lambert SA: Management Statement 24
Groupe Bruxelles Lambert SA: Locations and Subsidiaries 27
Groupe Bruxelles Lambert SA: Key Competitors 28
Groupe Bruxelles Lambert SA: Company Analysis 29
Groupe Bruxelles Lambert SA: Business Description 29
Groupe Bruxelles Lambert SA: SWOT Analysis 31
Groupe Bruxelles Lambert SA: SWOT Overview 31
Groupe Bruxelles Lambert SA: Strengths 31
Groupe Bruxelles Lambert SA: Weaknesses 32
Groupe Bruxelles Lambert SA: Opportunities 32
Groupe Bruxelles Lambert SA: Threats 33
Groupe Bruxelles Lambert SA: Corporate Financial Deals Activity 34
Groupe Bruxelles Lambert SA: Financial Deals Overview 34
Groupe Bruxelles Lambert SA: Targets and Partners 36
Groupe Bruxelles Lambert SA: Top Deals 2014 – 2018YTD* 37
Groupe Bruxelles Lambert SA: Mergers and Acquisitions 38
Groupe Bruxelles Lambert SA: Capital Raising 39
Groupe Bruxelles Lambert SA: Recent Developments 40
Groupe Bruxelles Lambert SA: News and Events Summary 40
Groupe Bruxelles Lambert SA: Business Expansion 41
Groupe Bruxelles Lambert SA: Financial Deals 41
Groupe Bruxelles Lambert SA: Financial Performance 41
Groupe Bruxelles Lambert SA: Strategy and Operations 42
Appendix 44
Contact Us 44
Methodology 44
About MarketLine 45

List of Tables
Table 1: Groupe Bruxelles Lambert SA: Key Facts
Table 2: Groupe Bruxelles Lambert SA: Key Employees
Table 3: Groupe Bruxelles Lambert SA: Company History
Table 4: Groupe Bruxelles Lambert SA: Locations and Subsidiaries
Table 5: Groupe Bruxelles Lambert SA: Key Competitors
Table 6: Groupe Bruxelles Lambert SA: Deal Activity by Deal Type - Volume (TTM*)
Table 7: Groupe Bruxelles Lambert SA: M&A Activity by Geography (TTM*)
Table 8: Groupe Bruxelles Lambert SA: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 9: Groupe Bruxelles Lambert SA: M&A Average Deal Size - Value (US$m)
Table 10: Groupe Bruxelles Lambert SA: Targets and Partners
Table 11: Groupe Bruxelles Lambert SA: Top Deals 2014 - 2018YTD*
Table 12: Groupe Bruxelles Lambert SA: M&A Volume and Value Trend (2014 - YTD*2018)
Table 13: Groupe Bruxelles Lambert SA: M&A Activity by Geography (2014 - YTD*2018)
Table 14: Groupe Bruxelles Lambert SA: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Table 15: Groupe Bruxelles Lambert SA: Capital Raising by Deal Type (2014 - YTD*2018)
Table 16: Groupe Bruxelles Lambert SA: News and Events Summary
Table 17: Groupe Bruxelles Lambert SA: Business Expansion
Table 18: Groupe Bruxelles Lambert SA: Financial Deals
Table 19: Groupe Bruxelles Lambert SA: Financial Performance
Table 20: Groupe Bruxelles Lambert SA: Strategy and Operations

List of Figures
Figure 1: Groupe Bruxelles Lambert SA: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Groupe Bruxelles Lambert SA: M&A Activity by Geography (TTM*)
Figure 3: Groupe Bruxelles Lambert SA: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 4: Groupe Bruxelles Lambert SA: M&A Average Deal Size - Value (US$m)
Figure 5: Groupe Bruxelles Lambert SA: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 6: Groupe Bruxelles Lambert SA: M&A Activity by Geography (2014 - YTD*2018)
Figure 7: Groupe Bruxelles Lambert SA: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Figure 8: Groupe Bruxelles Lambert SA: Capital Raising by Deal Type (2014 - YTD*2018)

★海外企業調査レポート[Groupe Bruxelles Lambert SA：企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Tecpetrol S.A.：企業の戦略・SWOT・財務情報
    Tecpetrol S.A. - Strategy, SWOT and Corporate Finance Report Summary Tecpetrol S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Antibe Therapeutics Inc (ATE)：医療機器：M&Aディール及び事業提携情報
    Summary Antibe Therapeutics Inc (Antibe) is a biotech company that designs and develops drug candidates for chronic pain and inflammation; and regenerative medicine. The company discovers and commercializes novel drugs, biologics and medical devices. It offers lead compound ATB-346, a naproxen deriv …
  • JCB Co., Ltd.：企業の戦略・SWOT・財務情報
    JCB Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary JCB Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Ascendance Biotechnology Inc-医療機器分野：企業M&A・提携分析
    Summary Ascendance Biotechnology Inc (Ascendance), formerly Hepregen Corp is a healthcare products provider that offers cell based assay products. The company provides vitro micro-liver cell-based platforms for use in safety testing, and pharmaceutical, biotherapeutic and diagnostic product developm …
  • Mimetogen Pharmaceuticals Inc-製薬・医療分野：企業M&A・提携分析
    Summary Mimetogen Pharmaceuticals Inc (Mimetogen) is a clinical stage biotechnology company that develops the use of peptidomimetics for the treatment of ophthalmic diseases. The company’s lead compound, MIM-D3, which is in Phase 3 clinical study used for the treatment of dry eye syndrome. It also o …
  • Hunting PLC (HTG)-石油・ガス分野：企業M&A・提携分析
    Summary Hunting PLC (Hunting) is a provider of energy services that manufactures and distributes products for the extraction of oil and gas. The company provides products for the construction, completion, and re-completion of wellbore development, and intervention and subsea support of wellbore prod …
  • Daiwa Securities Group Inc：企業のM&A・事業提携・投資動向
    Daiwa Securities Group Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Daiwa Securities Group Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acqui …
  • Centene Corp (CNC)-製薬・医療分野：企業M&A・提携分析
    Summary Centene Corp (Centene) is a healthcare service provider that offers services to government sponsored healthcare programs with focus on under-insured and uninsured individuals. It provides health plans through Medicaid, Medicare and Health Insurance Marketplace contracts; and other health sol …
  • PetVivo Holdings Inc (PETV)：企業の製品パイプライン分析2018
    Summary PetVivo Holdings Inc (PetVivo Holdings), formerly Technologies Scan Corp, is a biomedical device company. The company offers licensing and commercialization of medical devices and therapeutics to treat pets and animals suffering from arthritis and other afflictions. Its products include Kush …
  • Votorantim SA：企業の戦略的SWOT分析
    Votorantim SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Mitochon Pharmaceuticals Inc-製薬・医療分野：企業M&A・提携分析
    Summary Mitochon Pharmaceuticals Inc (Mitochon Pharma) is a biotechnology company that develops drugs for neurodegenerative and neuromuscular diseases. The company’s pipeline products include mitochondrial modulators such as MP-101, MP-201 and MP-301. It targets diseases such as batten disease, stro …
  • Metsa Tissue Corp：企業の戦略的SWOT分析
    Metsa Tissue Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Fujifilm SonoSite Inc-医療機器分野：企業M&A・提携分析
    Summary Fujifilm SonoSite Inc (Fujifilm SonoSite), a subsidiary of Fujifilm Holdings Corp, is a medical device company. It designs and develops ultrasound systems for use in a variety of medical specialties including anesthesiology, cardiology, critical care, endocrinology, orthopedic surgery, radio …
  • Air China Limited：企業の戦略・SWOT・財務情報
    Air China Limited - Strategy, SWOT and Corporate Finance Report Summary Air China Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Vivus Inc (VVUS)：企業の財務・戦略的SWOT分析
    Vivus Inc (VVUS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Clinigen Group Plc (CLIN)：企業の財務・戦略的SWOT分析
    Summary Clinigen Group Plc (Clinigen Group) is a pharmaceutical and services company that provides access to clinical trials, medicines, unlicensed and commercial supply. The company acquires and licenses essential commercial medicines such as foscavir, cardioxane, ethyol, savene and vibativ. It off …
  • Cholamandalam Investment and Finance Company Ltd (CHOLAFIN)：企業の財務・戦略的SWOT分析
    Cholamandalam Investment and Finance Company Ltd (CHOLAFIN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the comp …
  • Kiewit Corp：企業の戦略的SWOT分析
    Kiewit Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Purdue Pharma LP-製薬・医療分野：企業M&A・提携分析
    Summary Purdue Pharma LP (Purdue) is a privately held, US-based pharmaceutical company which develops pharmacologic therapies for the treatment and management of pain. The company undertakes the research, development, manufacture and marketing of prescription medicines and over-the-counter (OTC) med …
  • Vietnam National Petroleum Group (PLX)：企業の財務・戦略的SWOT分析
    Vietnam National Petroleum Group (PLX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆